|
| |
| | | 57417 | | 27.09.2006 | | UCB-Pharma SA | | 15.12.2006 | | | | | | | | | | | 01.08. | | | | 01.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Neupro 2 mg/24h | dispositif transdermique | () | N04BC09 | CI | | 02 | Neupro 4 mg/24h | dispositif transdermique | () | N04BC09 | CI | | 03 | Neupro 6 mg/24h | dispositif transdermique | () | N04BC09 | CI | | 04 | Neupro 8 mg/24h | dispositif transdermique | () | N04BC09 | CI | | 05 | Neupro 1 mg/24h | dispositif transdermique | () | N04BC09 | CI | | 06 | Neupro 3 mg/24h | dispositif transdermique | () | N04BC09 | CI | | 07 | Neupro 1 mg/24h | dispositif transdermique | | N04BC09 | CI | | 08 | Neupro 2 mg/24h | dispositif transdermique | | N04BC09 | CI | | 09 | Neupro 3 mg/24h | dispositif transdermique | | N04BC09 | CI | | 10 | Neupro 4 mg/24h | dispositif transdermique | | N04BC09 | CI | | 11 | Neupro 6 mg/24h | dispositif transdermique | | N04BC09 | CI | | 12 | Neupro 8 mg/24h | dispositif transdermique | | N04BC09 | CI |
|
|
|
